期刊文献+

异基因造血干细胞移植后胰腺相关指标异常患者的临床特点和影响因素分析

Clinical Characteristics and Influencing Factors of Patients with Abnormal Pancreatic Parameters after Allogeneic Hematopoietic Stem Cell Transplantation
下载PDF
导出
摘要 目的研究分析异基因造血干细胞移植(allo-HSCT)后胰腺相关指标异常患者的临床特征和影响因素。方法选取2019年3月至2020年6月于广东省人民医院行allo-HSCT的血液肿瘤患者共54例,按照血清淀粉酶指标是否有异常升高分为异常组和正常组,回顾性分析两组性别、年龄、病因、移植前疾病状态、干细胞来源、供受者关系、HLA配型、胆结石病史、高甘油三酯血症病史、高胆固醇血症病史、预处理方案、移植物抗宿主病预防方案、环孢素A浓度水平各项指标和胰腺相关指标异常升高的关系。结果54例患者中有11例(20.4%)出现了血淀粉酶的升高,其中10例伴有血脂肪酶的升高,有3例(5.6%)确诊为急性胰腺炎。多因素分析结果显示,有高胆固醇血症病史、应用改良全身照射/环磷酰胺预处理方案为导致胰腺相关指标异常升高的独立危险因素(P<0.05)。结论allo-HSCT患者要重视高胆固醇血症病史的存在和预处理方案的使用,早期采取合理的干预措施,有助于防止急性胰腺炎的发生。 Objective To analyze the clinical characteristics and influencing factors of patients with abnormal pancreatic related indicators after allogeneic hematopoietic stem cell transplantation(allo-HSCT).Methods A total of 54 patients with hematological malignancies underwent allo-HSCT in Guangdong Provincial People's Hospital from March 2019 to June 2020 were selected,and they were divided into abnormal group and normal group according to whether there was abnormal increase of serum amylase.The relationship between gender,age,etiology,disease status before transplantation,source of stem cells,donor recipient relationship,HLA matching,history of gallstone,history of hypertriglyceridemia,history of hypercholesterolemia,conditioning regimen,graft-versus-host disease prevention,cyclosporine A concentration and abnormal elevation of pancreatic related indicators were analyzed retrospectively.Results Among the 54 patients,11(20.4%)had elevated serum amylase,10 of them had elevated serum lipase,and 3(5.6%)were diagnosed as acute pancreatitis.Multivariate analysis suggested that history of hypercholesterolemia and application of modified total body irradiation/cyclophosphamide regimen were independent risk factors for abnormal elevation of pancreatic related indicators.Conclusions It is important to pay attention to the history of hypercholesterolemia and the application of conditioning regimen of patients receiving allo-HSCT,and it will be helpful to take reasonable intervention measures in the early stage to prevent the occurrence of acute pancreatitis.
作者 王惊华 曾高淳 张维娅 翁建宇 凌伟 罗成伟 曾祥佑 吴穗晶 WANG Jing-hua;ZENG Gao-chun;ZHANG Wei-ya;WENG Jian-yu;LING Wei;LUO Cheng-wei;ZENG Xiang-you;WU Sui-jing(Department of Hematology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China)
出处 《循证医学》 2020年第3期181-185,共5页 The Journal of Evidence-Based Medicine
基金 广东省医学科学技术研究基金项目(A2019063) 广东省人民医院(广东省医学科学院)高水平医院“登峰计划”科研专项(DFJH201803) 广东省医学科研基金项目(2013022) 华南理工大学中央高校基本科研业务费资助项目(D2180600) 广东省人民医院(广东省医学科学院)科技专项博士启动项目(2018bq01)。
关键词 异基因造血干细胞移植 血清淀粉酶 影响因素 allogeneic hematopoietic stem cell transplantation(allo-HSCT) serum amylase influencing factors
  • 相关文献

参考文献2

二级参考文献31

  • 1邬国和,赵恒,张华,李东宁,颜丽华,李萍,张晋湘.同胞异基因外周血干细胞移植治疗白血病研究[J].中国实验血液学杂志,2004,12(6):821-824. 被引量:1
  • 2蓝瑞琼,蒋亚斌.国产乌司他丁治疗急性胰腺炎的系统评价[J].中华消化杂志,2005,25(10):618-619. 被引量:22
  • 3Takeda K, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis : medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg, 2006,13:42-47.
  • 4Beger HG, Rau B, Isenmann R, et al. Antibiotic prophylaxis in severe acute panereatitis. Pancreatology, 2005,5:10-19.
  • 5Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut,2005,54 Suppl 3 : iii1-iii9.
  • 6Pezzilli R, Fantini L, Morselli Labate AM. New approaches for the treatment of acute pancreatitis. JOP, 2006,7:79-91.
  • 7Mofidi R, Duff MD, Wigmore SJ, et al. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg, 2006,93 :738-744.
  • 8Chen CC, Wang SS, Lee FY. Action of antiproteases on the inflammatory response in acute panereatitis. JOP, 2007,8 (4 Suppl) : 488-494.
  • 9Seta T, Noguchi Y, Shimada T, et al. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol, 2004,16 : 1287 1293.
  • 10Heinrieh S, Schafer M, Rousson V, et al. Evidence based treatment of acute pancreatitis: a look at established paradigms. Ann Surg, 2006,243 : 154-168.

共引文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部